.... time for a Class Action me thinks ..... all this talk of deals and commercial in confidence discussions over the years from the previous CEO and the company is going backwards with no license deals to speak of ?
Starpharma are either outpricing themselves in the market for our DEP tech or companies that have researched it for years are now starting to walk away without signing anything because the science isn't as good as the company or the likes of @Gumnut70 @antibotter @bid etc continually claim ....
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $12.03K | 116.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 109616 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |